What Happened to Senti Biosciences?
Ticker: SNTISPAC Year: 2021Merger: 2022
Return
-91.0%
Current Price
$0.9
Peak Price
$105.4
Trust Size
$53M
Summary
Senti Biosciences is a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary gene circuit technology platform.
What Happened
Senti Biosciences went public through a SPAC merger and trades under SNTI. The company engineers synthetic biology 'gene circuits' that can be programmed into cell therapies to make them smarter and more effective against cancer. The stock has declined significantly and the company faces the typical challenges of a pre-revenue clinical-stage biotech, with a reverse stock split executed to maintain listing compliance.
Timeline
2021-05-21
S-1 Registration Filed
2022-05-13
Merger Proxy Filed (DEFM14A)